Researcher Spotlight: Alexandre Vinaud Hirayama, MD Fred Hutchinson Cancer Research Center Chimeric antigen receptor (CAR)…
Researcher Spotlight: Marco Ruella, MD Perelman School of Medicine, University of Pennsylvania Chimeric antigen receptor…
In 2015, Stacy-Humphrie's diffuse large B-Cell lymphoma (DLBCL) relapsed and she was faced with a tough decision - to follow the standard of care and receive a stem cell transplant, or opt for a new treatment called CAR-T cell therapy which at the time, was still in the clinical trial phase.
Researcher Spotlight: Natalie Grover, MD The University of North Carolina at Chapel Hill Although a…
Researcher Spotlight: Yong Gu Lee, PhD The Trustees of the University of Pennsylvania Diffuse…
Researcher Spotlight: Raghuveer Ranganathan, MD University of North Carolina, Chapel Hill Though CAR T-cell therapy…
Researcher Spotlight: Irene Scarfo, PhD Massachusetts General Hospital The majority of chimeric antigen receptor (CAR)…
Researcher Spotlight: Antonia Rotolo, MD, PhD University of Pennsylvania Perelman School of Medicine Researchers are…
Researcher Spotlight: Ashley D. Staton, MD Winship Cancer Institute, Emory University Dr. Staton is…